Geriatric chronic kidney disease patients benefit from SGLT2 inhibition
News-Medical26 Oct · 13:28← Topics · 26 Oct
Development ↘
Development ↘
Cureus26 Oct · 12:18
Development ↘
Development ↘
Development ↘
Development ↘
Newswise26 Oct · 00:38
As it stood that day
SGLT2 inhibitors are helping older adults with chronic kidney disease.
10 reports · 26 Oct
Summary · from headlines3 points
- Tegoprubart improves quality of life versus tacrolimus after kidney transplant.
- CT KUB detects ureteric calculi in an outpatient population.
- A study finds eGFR underestimates chronic kidney disease in patients with cancer.
Latest developments6 to read first
High-Dose Vitamin D of No Benefit in Dialysis
Medscape26 Oct · 07:48Renal hyperfiltration dynamics as a cardiovascular risk stratification marker
Nature26 Oct · 05:48eGFR Underestimates CKD in Patients with Cancer, Study Finds
HCPLive26 Oct · 02:28Timeline 10 reports
26 Oct 202610 reports
13:001 report
12:001 report
11:00nothing heard
10:00nothing heard
09:00nothing heard
08:00nothing heard
07:001 report
06:00nothing heard
05:001 report
04:00nothing heard
03:00nothing heard
02:001 report
01:00nothing heard
00:005 reports
← Topics · 26 OctOne topic